Mark Currie
Direktor/Vorstandsmitglied bei IRONWOOD PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 31.05.2024
Profil
Mark G.
Currie currently works at Science Exchange, Inc., as Director from 2020, Sea Pharmaceuticals LLC, as Director from 2021, and Ironwood Pharmaceuticals, Inc., as Independent Director from 2019.
Dr. Currie also formerly worked at Monsanto Co., as Director-Arthritis & Inflammation, G.D.
Searle & Co., Inc., as Director-Arthritis & Inflammation, Sumitomo Pharma America, Inc., as Vice President-Discovery Research from 1999 to 2002, Ironwood Pharmaceuticals, Inc., as Chief Scientific Officer, President-R&D, Senior VP from 2002 to 2019, and Cyclerion Therapeutics, Inc., as President & Chief Scientific Officer from 2019 to 2020.
Dr. Currie received his doctorate degree from Wake Forest School of Medicine and undergraduate degree from the University of South Alabama.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.03.2024 | 544 108 ( 0,34% ) | 3 Mio $ | 31.05.2024 |
Aktive Positionen von Mark Currie
Unternehmen | Position | Beginn |
---|---|---|
IRONWOOD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2019 |
Science Exchange, Inc.
Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 12.02.2020 |
Sea Pharmaceuticals LLC
Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.02.2021 |
Ehemalige bekannte Positionen von Mark Currie
Unternehmen | Position | Ende |
---|---|---|
CYCLERION THERAPEUTICS, INC. | Präsident | 01.12.2020 |
IRONWOOD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2019 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01.08.2002 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - |
MONSANTO | Corporate Officer/Principal | - |
Ausbildung von Mark Currie
Wake Forest School of Medicine | Doctorate Degree |
University of South Alabama | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
CYCLERION THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Monsanto Co.
Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Science Exchange, Inc.
Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Technology Services |
Sea Pharmaceuticals LLC
Sea Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sea Pharmaceuticals LLC manufactures and markets pharmaceutical products and services. The company is headquartered in Cambridge, MA. | Health Technology |